Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
page
news-articles
tribe_events
Donate

Erythrokeratodermia Cardiomyopathy Syndrome

What Is Erythrokeratodermia Cardiomyopathy Syndrome (EKC)?


Erythrokeratodermia cardiomyopathy (EKC) syndrome is a rare type of congenital skin and heart disease. The name comes from the two defining features of the disease: red, scaly skin (erythrokeratodermia) and heart issues (cardiomyopathy). The disease is caused by damaging genetic variants in the DSP gene which is important for maintaining the integrity of the skin and the heart to mechanical stress.


Longterm Course


Failure to thrive in infancy and childhood; sudden cardiac death or heart failure may occur; treatment with ustekinumab significantly improves skin and heart disease and failure to thrive.2–4


Key Findings

  • Skin
    ichthyosis, generalized erythrokeratodermia; some cases show pustular flares which may be associated with bacterial skin infections. 
  • Hair
    Wooly hair; alopecia has been reported in some cases; lighter hair than other family members in some cases
  • Nails
    Oncodystrophy

Associated Findings

  • Cardiac
    Dilated cardiomyopathy (left ventricle dominant)2, heart failure, myocarditis
  • Other
    Failure to thrive, secondary tooth agenesis, enamel issues, recurrent dental caries

What are the Signs & Symptoms?

Although EKC follows an autosomal dominant pattern of inheritance, most reported cases occur sporadically, meaning there is usually only one affected individual in a family. 
At birth, individuals with EKC may show red, scaly skin and may show increased skin infections. Individuals with EKC commonly have a lack of eyebrows and eyelashes at birth.1 Occasionally, heart issues may be present at birth causing feeding difficulties, skin color changes, and increased irritability. However, in many cases, heart issues do not develop until infancy or childhood.

Individuals with EKC experience ichthyosis (scaling skin), redness and may experience flares where their skin disease gets worse due to bacterial infection, stress, or other triggers. They may also have issues with their fingernails and toenails, issues with their teeth such as gum infections,  and hair issues. Some individuals have alopecia (lack of hair) while others have hair that is “woolier” or thicker than other family members and some with EKC have lighter hair color than other family members. Occasionally, individuals with EKC will experience issues with their eye such as cloudy spots in their cornea.2 

Individuals with EKC may show signs of heart issues during infancy or childhood including poor feeding difficulties (in infants), rapid breathing, excessive sweating or fatigue while eating or playing. Occasionally, individuals with EKC may experience chest pain, shortness of breath, or rapid/abnormal heart rhythms acutely which may get diagnosed as myocarditis (or inflammation of the hart). It is very important to pay attention to signs and symptoms which may signal heart disease since sudden cardiac death or heart failure can occur in individuals with EKC.

Lastly, individuals with EKC show failure to thrive, meaning they fail to grow and gain weight at the same rate as other children. 

How is it Diagnosed?

The skin symptoms of EKC may cause individuals to be diagnosed with ichthyosis or other related disorders which have red, scaly skin such as Netherton syndrome, psoriasis, or pityriasis rubra pilaris. 
Heart workup includes electrocardiogram to measure the heart rhythm and echocardiogram to measure structural characteristics of the heart. Most individuals with EKC show normal heart rhythm but abnormal structure, specifically dilation of the left ventricle.2 Given the risk of sudden cardiac death or heart failure, anyone experiencing signs and symptoms of EKC or observing these symptoms in their child should undergo cardiac evaluation as promptly as possible. 

Diagnosis of EKC is confirmed if genetic testing shows damaging variants in the desmoplakin (DSP) gene. You can participate in research studies and also receive genetic testing through the National Ichthyosis Registry at Yale University or for more information about genetic tests performed you can visit GeneDx, www.genedx.com

What is the Treatment?

Individuals with EKC respond well to certain anti-inflammatory medications repurposed from psoriasis, namely ustekinumab. These medications improve skin and hair symptoms, lead to height and weight gain, and can also improve heart issues. 2–4 

Additionally, antisepsis (such as use of bleach baths) may help in some cases, and care should be taken to monitor for bacterial and fungal infections of the skin, which should be treated appropriately with antibiotics or antifungals. 

Given the serious heart issues associated with EKC and the efficacy of anti-inflammatory therapies, individuals and families with EKC should seek treatment from both a dermatologist and cardiologist with experience treating genetic diseases. 

References
  1. Boyden, L. M. et al. Dominant de novo DSP mutations cause erythrokeratodermia-cardiomyopathy syndrome. Human Molecular Genetics 25, 348–357 (2016).
  2. Sun, Q., Wine Lee, L., Hall, E. K., Choate, K. A. & Elder, R. W. Hair and skin predict cardiomyopathies: Carvajal and erythrokeratodermia cardiomyopathy syndromes. Pediatric Dermatology 38, 31–38 (2021).
  3. Paller, A. S. et al. The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab. Journal of the American Academy of Dermatology 78, 498-505.e2 (2018).
  4. Hamzehlou, S. et al. Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions. Pediatr Dermatol https://doi.org/10.1111/pde.70048 (2025) doi:10.1111/pde.70048.

Clinical Resources

Phenotype Names

Erythrokeratodermia cardiomyopathy syndrome, dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis

EDD Name

KRT16-pEDD

OMIM

615821

Inheritance

Autosomal Dominant

Incidence

Exceptionally rare, less than 25 cases reported, incidence of ~ 0.1–0.5 per million births based on a de novo mutation rate for DSP SR6 EKC variants.1

Diagnostic Tests

Genetic testing of blood or saliva, electrocardiogram, echocardiogram

Age of First Appearance

Often at birth or during infancy; some may experience milder disease and some may not show symptomatic heart disease.3

Abnormal Gene

Desmoplakin (DSP)

Primary Symptom Photos

Related Information